Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases

Active Publication Date: 2016-12-01
BIOLAMINA
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes methods for growing stem cells in a way that allows for increased cellular homogeneity. Additionally, it explains how to remove stem cells from their current culturing environment and replat them in a single cell suspension for further expansion and passaging. By doing so, researchers can produce larger amounts of stem cells for use in various applications.

Problems solved by technology

However, a major hurdle remains in generating standardized good manufacturing practices (GMP)-grade human pluripotent stem (hPS) cell-based progenitors that upon transplantation will mature and function in the adult brain.
As cells are transplanted as immature progenitors and full maturation into functionally integrated neurons requires 6 months or longer in vivo, transplanted cells cannot be assessed for functionality prior to transplantation, and there is a lack of markers that reliably predict yield and maturation of the immature progenitors.
This can pose a significant hurdle for the generation of cells for larger cohorts of patients and for launching a standardized stem cell product to the clinic.
Moreover, grafts generated from these protocols do not result in cell overgrowths or tumor formation, thus making them suitable candidate cells for stem cell replacement therapies.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases
  • Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases
  • Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases

Examples

Experimental program
Comparison scheme
Effect test

example 1

Materials and Methods

[0124]Neural induction medium (NIM), Y-27632 (10 μM), SB431542 (10 μM) and noggin (100 ng / mL) were combined to create a differentiation medium. Approximately 250 μL of medium was needed per cm2 of differentiation. For patterning to ventral mesencephalic fates, 0.6 to 1.0 μM CHIR99021 and 200 ng / mL Shh-C24II was added to the medium.

[0125]Colonies appeared pluripotent and any differentiated colonies were removed from the culture before initiating differentiation. StemMACS iPSBrew medium was aspirated and cells washed once in PBS. EDTA (0.5 mM) was added to the cells and the cells incubated at room temperature for about 7 minutes. The plate was rocked occasionally to ensure the cells were submerged in EDTA.

[0126]10 mL wash medium (DMEM / F12 with 0.1% albumin or other medium similar to growth medium) was prepared in a 15 mL tube. EDTA was removed and 1 mL wash medium was transferred to the plate.

[0127]Colonies were immediately pipetted off the dish with a pipette and...

example 2

Materials and Methods

[0141]The same materials and protocol disclosed in Example 1 are used for 24 well plates with the following alterations:

[0142]Plates were coated with laminin-111 (1 μg / cm2) in PBS and Ca2+ / Mg2+ (700 μL / cm2). For seeding the cell suspension onto the laminin-111 coated plates, approximately 250 μL was required per cm2 (500 μL / well). To initiate differentiation, for 6 wells of a 24 well plate, 120,000 cells in total were needed.

[0143]At the 96 hour and 168 hour marks after plating, approximately 600 μL medium was added to each well. At the 216 hour mark after plating, approximately 700 μL medium was added to each well.

[0144]Some cell lines required the addition of 10 μM Y-27632 to the medium to survive replating. During replating, approximately 150 μL accutase was added to each well. At the 336 hour mark, approximately 700 μL medium was added per well.

example 3

Preparation of Cells for Transplantation (Day 16-25)

[0145]The same materials and protocol disclosed in Examples 1 and 2 are used.

[0146]Cells were maintained in B27M, BAG (BDNF+AA+GDNF), and FGF8b until the day of transplantation without any further manipulations. Medium was refreshed every 2-3 days. Cells were most suitable for transplantation on day 16 but could be transplanted up until day 26. Cells for transplantation did not receive DAPT or db-cAMP in the medium, as this would result in premature neuronal maturation and increased cell death upon dissociation.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present disclosure relates to methods for producing dopaminergic cells and evaluating their functionality. When pluripotent human embryonic stem cells are cultured on plates coated with laminin-111, laminin-121, laminin-521, laminin-421, or laminin-511 in cell culture medium containing a GSK3 inhibitor and a TGF-β inhibitor as well as timely administered fibroblast growth factor, desired neural cells are produced at far higher rates. Useful cell culture kits for producing such dopaminergic cells are also described herein, as are methods of using such cells for stem cell therapy.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims priority to U.S. Provisional Patent Application Ser. No. 62 / 300,000, filed Feb. 25, 2016; and to U.S. Provisional Patent Application Ser. No. 62 / 182,051, filed Jun. 19, 2015; and to U.S. Provisional Patent Application Ser. No. 62 / 145,467, filed Apr. 9, 2015; the disclosures of which are hereby fully incorporated by reference.BACKGROUND[0002]This application incorporates by reference the material in the ASCII text file named “Seq_List_LCTI_200040USP3_ST25.txt”, which was created on Feb. 10, 2016, and has a file size of 8,781 bytes.[0003]The present disclosure relates to methods for producing certain desired dopaminergic cells from human pluripotent stem cells (hESCs) and for predicting their phenotypic maturation after transplantation to the brain based on molecular markers. These dopaminergic cells can then be used in stem cell based therapies such as for treating neurodegenerative diseases including Parkinson's di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/0797A61K35/30
CPCC12N5/0623A61K35/30C12N2533/52C12N2501/13C12N2501/727C12N2501/15C12N2501/119C12N2501/41C12N2501/405C12N2506/02C12N2500/38A61K35/545C12N5/0619C12N2501/999A61P25/16A61P25/28
Inventor KIRKEBY, AGNETEPARMAR, MALIN PERNILLA
Owner BIOLAMINA